Cerebral venous thrombosis: Novel risk factors and advances in treatment

A.A.G.A. van de Munckhof

Cerebral venous thrombosis: Novel risk factors and advances in treatment

A.A.G.A. van de Munckhof

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

Cerebral venous thrombosis (CVT) is a severe disease that primarily affects patients younger than 50 years. In 2021, CVT was found to be a rare side effect of SARS-CoV-2 vaccinations, which caused a major public concern. This vaccine-associated condition, in which patients developed both thrombosis and low platelet counts, was named vaccine-induced immune thrombotic

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	Universiteit van Amsterdam
Supervisors/Advisors	Roos, Yvo, Supervisor Coutinho, Jonathan, Supervisor
Award date	15 Oct 2025
Print ISBNs	9789465226361
Publication status	Published - 2025

Access to Document

https://pure.uva.nl/ws/files/257509257/Thesis.pdf

Cite this

@phdthesis{f08e3236e0074c89a82571dbbf7dd4db,

title = "Cerebral venous thrombosis: Novel risk factors and advances in treatment",

abstract = "Cerebral venous thrombosis (CVT) is a severe disease that primarily affects patients younger than 50 years. In 2021, CVT was found to be a rare side effect of SARS-CoV-2 vaccinations, which caused a major public concern. This vaccine-associated condition, in which patients developed both thrombosis and low platelet counts, was named vaccine-induced immune thrombotic",

author = "\{van de Munckhof\}, A.A.G.A.",

year = "2025",

language = "English",

isbn = "9789465226361",

type = "Phd-Thesis - Research and graduation internal",

school = "Universiteit van Amsterdam",

}

TY - THES

T1 - Cerebral venous thrombosis

T2 - Novel risk factors and advances in treatment

AU - van de Munckhof, A.A.G.A.

PY - 2025

Y1 - 2025

N2 - Cerebral venous thrombosis (CVT) is a severe disease that primarily affects patients younger than 50 years. In 2021, CVT was found to be a rare side effect of SARS-CoV-2 vaccinations, which caused a major public concern. This vaccine-associated condition, in which patients developed both thrombosis and low platelet counts, was named vaccine-induced immune thrombotic

AB - Cerebral venous thrombosis (CVT) is a severe disease that primarily affects patients younger than 50 years. In 2021, CVT was found to be a rare side effect of SARS-CoV-2 vaccinations, which caused a major public concern. This vaccine-associated condition, in which patients developed both thrombosis and low platelet counts, was named vaccine-induced immune thrombotic

M3 - Phd-Thesis - Research and graduation internal

SN - 9789465226361

ER -

Cerebral venous thrombosis: Novel risk factors and advances in treatment

Abstract

Access to Document

Fingerprint

Cite this